AiVita Biomedical
Latest round
- Series A
Last raised
- Jun 2016
Total raised
- $2M
Investors
- 1
About AiVita Biomedical
AiVita Biomedical, Inc.Founded in 2016 and headquartered in Irvine, US, AiVita Biomedical, Inc. focuses on personalized vaccine solutions.AiVita Biomedical develops personalized vaccines that focus on combating cancer and infectious diseases. Their offerings include a cancer vaccine that targets all neoantigens, improving efficacy against evolving cancer mutations, and a multi-pathogen vaccine kit designed to boost adaptive immunity against various pathogens.AiVita Biomedical generates revenue primarily through partnerships and licensing agreements with healthcare institutions and research organizations. Upcoming initiatives include the design of new vaccines targeting additional cancer types and emerging infectious diseases. The company aims to penetrate new geographic markets in Asia and Europe by the end of 2023, aligning with its strategic growth objectives.
Who invested in AiVita Biomedical
1 investor across 1 round
See all investors in AiVita Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 10, 2016
Amount
$2M
Investors
Questions about AiVita Biomedical
Who invested in AiVita Biomedical?
AiVita Biomedical has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AiVita Biomedical raised?
AiVita Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AiVita Biomedical last raise money?
AiVita Biomedical's most recent round on record is a Series A, in Jun 2016.
What does AiVita Biomedical do?
AiVita Biomedical is a biotechnology company.
Where is AiVita Biomedical headquartered?
AiVita Biomedical is headquartered in Irvine, US.
Which VCs invest in companies like AiVita Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AiVita Biomedical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AiVita Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.